Stockreport

Pluristem Therapeutics Inc. Announces Pricing of Its Public Offering and Registered Direct Offering for Aggregate Proceeds of Approximately $20 Million

Pluristem Therapeutics, Inc.  (PSTI) 
Last pluristem therapeutics, inc. earnings: 2/6 04:10 pm Check Earnings Report
US:NASDAQ Investor Relations: pluristem.com
PDF HAIFA, Isreal, April 04, 2019 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq: PSTI, TASE: PLTR) (“Pluristem” or “Company”), a leading regenerative medicine co [Read more]